| Literature DB >> 21559234 |
Gianluca Castelnuovo1, Gian Mauro Manzoni, Valentina Villa, Gian Luca Cesa, Enrico Molinari.
Abstract
This paper describes the results of the STRATOB (Systemic and STRATegic psychotherapy for OBesity) study, a two-arm randomized controlled clinical trial (RCT) comparing Brief Strategic Therapy (BST, Nardone or Arezzo model) with the gold standard CBT (Cognitive Behavioral Therapy) for the inpatient and telephone-based outpatient treatment of obese people with Binge Eating Disorder (BED) seeking treatment for weight reduction. Primary outcome measure of the randomized trial was change in the Global Index of the Outcome Questionnaire (OQ 45.2). Secondary outcome measures were BED remission (weekly binge episodes < 2) and weight loss. Data were collected at baseline, at discharge from the hospital (c.a. 1 month after) and after 6 months from discharge.. No significant difference between groups (BST vs CBT) was found in the primary outcome at discharge. However, a greater improvement was seen in the BST vs the CBT group (P<.01) in the primary outcome at 6 months. About secondary outcomes, no significant difference between groups were found in weight change both at discharge and at 6 months. Notably, a significant association emerged between treatment groups and BED remission at 6 months in favor of BST (only 20% of patients in BST group reported a number of weekly binge episodes > 2 vs 63.3% in CBT group).Entities:
Keywords: Brief strategic therapy – BST; binge-eating disorder – BED; clinical psychology; cognitive behavioural therapy – CBT; obesità; psychotherapy.; telecare
Year: 2011 PMID: 21559234 PMCID: PMC3089039 DOI: 10.2174/1745017901107010029
Source DB: PubMed Journal: Clin Pract Epidemiol Ment Health ISSN: 1745-0179
Baseline Participant Characteristics by Treatment Group
| Characteristic | CBT Group (n = 30) | BST Group (n = 30) | Total (N = 60) |
|---|---|---|---|
| 46,2 (10,5) | 45,9 (10,76) | 46,05 (10, 54) | |
| 30 | 30 | 60 | |
| 107, 37 (6,83) | 106,53 (7,14) | 106,95 (6,95) | |
| 48,47 (8,42) | 52,13 (11,19) | 50,3 (10) | |
| 24,40 (5,8) | 25,93 (7,61) | 25,17 (6,75) | |
| 19,50 (4,47) | 18,4 (4,64) | 18,95 (4,55) | |
| 92,37 (11,01) | 96,47 (10,22) | 94,42 (10,73) | |
| 2,83 (0,74) | 2,8 (0,8) | 2,82 (0,77) |
Data are given as mean (SD).
Differences Between CBT and BST Groups Considering Primary Outcome Measure (Change in the Global Index and Other Sub-Indexes of the OQ 45.2) and Secondary Outcome Measures (Percentage of BED Patients Remitted Considering the Number of Weekly Binge Episodes and the Weight Loss) at Discharge from the Hospital and After 6 Months
| 95% CI | ||||||||
|---|---|---|---|---|---|---|---|---|
| Outcomes (Primary and Secondaries) | N | Mean | s.d. | p | Effect size (Hedges) | Lower Bound | Upper Bound | |
| CBT | 30 | -2,7 | 3,49 | 0,556 | -0,15 | -0,66 | 0,36 | |
| BST | 30 | -3,2 | 3,04 | |||||
| CBT | 30 | -7,93 | 5,12 | -1,09 | -1,64 | -0,55 | ||
| BST | 30 | -14,1 | 5,98 | |||||
| CBT | 30 | -1,5 | 6,67 | 0,114 | -0,41 | -0,92 | 0,10 | |
| BST | 30 | -4,5 | 7,78 | |||||
| CBT | 30 | -2,2 | 10,3 | 0,408 | -0,21 | -0,72 | 0,29 | |
| BST | 30 | -4,47 | 10,78 | |||||
| CBT | 30 | -1,77 | 2,11 | 0,920 | 0,03 | -0,48 | 0,53 | |
| BST | 30 | -1,7 | 2,93 | |||||
| CBT | 30 | -4,33 | 2,93 | 0,205 | -0,33 | -0,84 | 0,18 | |
| BST | 30 | -5,57 | 4,38 | |||||
| CBT | 30 | -5,97 | 6,2 | 0,570 | -0,49 | -1,01 | 0,02 | |
| BST | 30 | -9,4 | 7,46 | |||||
| CBT | 30 | -14,47 | 12,07 | -1,09 | -1,63 | -0,55 | ||
| BST | 30 | -27,2 | 10,91 | |||||
| CBT | 30 | -6,3 | 2,36 | 0,152 | -0,37 | -0,88 | 0,14 | |
| BST | 30 | -7,12 | 2,02 | |||||
| CBT | 30 | -11,92 | 16,9 | 0,128 | -0,39 | -0,90 | 0,12 | |
| BST | 30 | -16,93 | 5,51 | |||||
| CBT | 30 | -5,96 | 17,90 | 0,191 | -0,34 | -0,85 | 0,17 | |
| BST | 30 | -10,53 | 6,14 | |||||
Within-Group Changes of Primary Outcome Measure (OQ 45.2 Global Index) and Secondary Outcome Measures (OQ 45.2 Sub-Indexes and Weight Loss) at Discharge from the Hospital and after 6 Months by Treatment Group (CBT and BST)
| 95% Confidence Interval of the Difference | ||||||
|---|---|---|---|---|---|---|
| Outcomes (Primary and Secondaries) | Group | N | Mean | Std. Deviation | Lower Bound | Upper Bound |
| CBT | 30 | -2,7 | 3,49 | -3,95 | -1,45 | |
| BST | 30 | -3,2 | 3,04 | -4,29 | -2,11 | |
| CBT | 30 | -7,93 | 5,12 | -9,77 | -6,10 | |
| BST | 30 | -14,1 | 5,98 | -16,24 | -11,96 | |
| CBT | 30 | -1,5 | 6,67 | -3,89 | ||
| BST | 30 | -4,5 | 7,78 | -7,29 | -1,71 | |
| CBT | 30 | -2,2 | 10,3 | -5,89 | ||
| BST | 30 | -4,47 | 10,78 | -8,32 | -0,61 | |
| CBT | 30 | -1,77 | 2,11 | -2,52 | -1,01 | |
| BST | 30 | -1,7 | 2,93 | -2,75 | -0,65 | |
| CBT | 30 | -4,33 | 2,93 | -5,38 | -3,29 | |
| BST | 30 | -5,57 | 4,38 | -7,13 | -4,00 | |
| CBT | 30 | -5,97 | 6,2 | -8,19 | -3,75 | |
| BST | 30 | -9,4 | 7,46 | -12,07 | -6,73 | |
| CBT | 30 | -14,47 | 12,07 | -18,79 | -10,15 | |
| BST | 30 | -27,2 | 10,91 | -31,10 | -23,30 | |
| CBT | 30 | -6,3 | 2,36 | -7,14 | -5,45 | |
| BST | 30 | -7,12 | 2,02 | -7,85 | -6,40 | |
| CBT | 30 | -11,92 | 16,9 | -17,97 | -5,87 | |
| BST | 30 | -16,93 | 5,51 | -18,91 | -14,96 | |
| CBT | 30 | -5,96 | 17,9 | -12,36 | ||
| BST | 30 | -10,53 | 6,14 | -12,73 | -8,33 | |